Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in non-small cell lung cancer patients with intestinal lung disease. A multicenter non randomized trial.

ABSTRACT: Interventions: Multicenter, single-arm, open-label trial Primary outcome(s): The pleural effusion control rate (30days after administration of hypotonic cisplatin for malignant pleural effusion) Study Design: Single arm Non-randomized

DISEASE(S): Interstitial Pneumonia Merger Stage Iv Non-small Cell Lung Cancer Case With The Malignant Pleural Effusion

PROVIDER: 2638358 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR